Indegene Ltd Technical Momentum Shifts Amid Bearish Signals

Technical Trend Overview

Recent analysis reveals that Indegene’s technical trend has deteriorated from mildly bearish to outright bearish. The Moving Average Convergence Divergence (MACD) on the weekly chart remains bearish, indicating sustained downward momentum. Although the monthly MACD does not currently provide a definitive signal, the weekly readings suggest that selling pressure is prevailing in the near term.

The Relative Strength Index (RSI) on both weekly and monthly timeframes shows no clear signal, hovering in neutral zones. This lack of momentum confirmation from RSI suggests that the stock is neither oversold nor overbought, but the absence of bullish RSI divergence adds to the cautious outlook.

Bollinger Bands further reinforce the bearish sentiment. On the weekly scale, the bands are signalling bearishness, with the price gravitating towards the lower band, indicating increased volatility and potential downside risk. The monthly Bollinger Bands are mildly bearish, suggesting that the longer-term trend is also under pressure but less severe than the short-term outlook.

Moving Averages and Other Indicators

Daily moving averages for Indegene are firmly bearish, with the stock price trading below key averages such as the 50-day and 200-day moving averages. This positioning typically signals a downtrend and may deter momentum-driven investors from initiating new positions.

The Know Sure Thing (KST) indicator on the weekly chart also aligns with the bearish narrative, confirming the downward momentum. However, monthly KST data is inconclusive, reflecting a lack of strong directional conviction over the longer term.

From a volume perspective, the On-Balance Volume (OBV) indicator shows no significant trend on the weekly chart, but the monthly OBV is mildly bearish. This suggests that volume flows are not strongly supporting price advances, which could limit any potential recovery in the near term.

Dow Theory assessments on both weekly and monthly timeframes indicate no clear trend, highlighting the stock’s current indecisiveness in broader market context.

Price and Volatility Snapshot

Indegene’s current price stands at ₹491.20, marginally down from the previous close of ₹491.50, reflecting a negligible day change of -0.06%. The stock’s intraday range on 10 Feb 2026 was between ₹488.00 and ₹494.70, indicating limited volatility within the session.

Over the past 52 weeks, the stock has traded between a low of ₹455.80 and a high of ₹636.75, showing a wide trading band of nearly ₹180.95. This range highlights the stock’s susceptibility to market swings and sector-specific developments.

Comparative Returns Analysis

When benchmarked against the Sensex, Indegene’s returns have underperformed significantly over multiple periods. The stock posted a modest 0.03% gain over the past week, compared to the Sensex’s robust 2.94% rise. Over one month, Indegene declined by 3.44%, while the Sensex gained 0.59%.

Year-to-date, the stock has fallen 5.64%, underperforming the Sensex’s 1.36% decline. The one-year return is particularly stark, with Indegene down 21.93% versus the Sensex’s 7.97% gain. Longer-term data for three, five, and ten years is unavailable for the stock, but the Sensex’s strong multi-year returns (38.25% over three years and 249.97% over ten years) underscore the stock’s relative weakness within the broader market.

Mojo Score and Rating Update

Indegene’s MarketsMOJO score currently stands at 50.0, reflecting a neutral stance. The Mojo Grade has recently been upgraded from Sell to Hold as of 12 Jan 2026, signalling a cautious improvement in outlook but not yet a definitive buy recommendation. The Market Cap Grade is rated 3, indicating a mid-tier market capitalisation relative to peers in the Healthcare Services sector.

This rating adjustment suggests that while the stock’s fundamentals and technicals have shown some stabilisation, investors should remain vigilant given the prevailing bearish technical signals and underperformance relative to the broader market.

Sector Context and Outlook

The Healthcare Services sector has been subject to mixed investor sentiment amid evolving regulatory frameworks and shifting demand dynamics. Indegene’s technical deterioration contrasts with some sector peers that have maintained stronger momentum, underscoring the importance of selective stock picking within this space.

Given the current technical indicators, including bearish MACD and moving averages, alongside neutral RSI and Dow Theory signals, the stock appears to be in a consolidation phase with a downward bias. Investors should monitor for any reversal signals such as a bullish MACD crossover or RSI moving above 50 to consider a more optimistic stance.

Investor Takeaway

For investors tracking Indegene Ltd, the current technical landscape advises caution. The bearish momentum across multiple indicators, combined with underwhelming relative returns versus the Sensex, suggests limited upside in the near term. The stock’s proximity to its 52-week low of ₹455.80 and failure to reclaim recent highs near ₹636.75 further emphasises the need for a disciplined approach.

Those with existing positions may consider tightening stop-loss levels or reducing exposure until clearer signs of trend reversal emerge. Prospective buyers should await confirmation of improved momentum, such as a sustained break above key moving averages or a positive MACD crossover on weekly charts.

Overall, Indegene’s technical profile aligns with a Hold rating, reflecting a neutral stance that balances potential risks and opportunities amid a challenging market environment.

Summary of Key Technical Metrics:

• Current Price: ₹491.20 (10 Feb 2026)
• 52-Week Range: ₹455.80 - ₹636.75
• MACD Weekly: Bearish
• RSI Weekly & Monthly: No Signal
• Bollinger Bands Weekly: Bearish; Monthly: Mildly Bearish
• Moving Averages Daily: Bearish
• KST Weekly: Bearish
• OBV Monthly: Mildly Bearish
• Dow Theory Weekly & Monthly: No Trend
• Mojo Score: 50.0 (Hold, upgraded from Sell on 12 Jan 2026)

Investors should continue to monitor these indicators closely as the stock navigates its current technical phase.

Unlock special upgrade rates for a limited period. Start Saving Now →